NeoGenomics
324 hedge funds and large institutions have $5.58B invested in NeoGenomics in 2021 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 105 increasing their positions, 107 reducing their positions, and 24 closing their positions.
103% more call options, than puts
Call options by funds: $21.5M | Put options by funds: $10.6M
71% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 24
11% more capital invested
Capital invested by funds: $5.03B → $5.58B (+$549M)
4% more funds holding
Funds holding: 311 → 324 (+13)
3.16% more ownership
Funds ownership: 91% → 94.15% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
2% less repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 107
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$96.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$94.3M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$54.2M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$46.7M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$37.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$61.7M |
| 2 |
FAM
Fred Alger Management
New York
|
-$53.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$22.5M |
| 4 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
-$22.2M |
| 5 |
CC
Casdin Capital
New York
|
-$22.1M |
NEO Hedge Fund Activity: Q3 2021 in Review
324 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2021, worth a combined $5.58B — up 11% from $5.03B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NEO positions and 24 closed out — a net gain of 17 holders — while 105 added to existing stakes and 107 trimmed.
The largest buyer was Artisan Partners, adding an estimated $96.6M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $61.7M sold.
- 324 institutional investors held NeoGenomics (NEO) as of Q3 2021, up from 311 in Q2 2021.
- Funds reported $5.58B of NeoGenomics stock for Q3 2021, up 11% quarter-over-quarter.
- 41 funds opened new NeoGenomics positions in Q3 2021 and 24 closed out, a net change of +17 holders.
- The largest NeoGenomics buyer in Q3 2021 was Artisan Partners, an estimated $96.6M added.
- The largest NeoGenomics seller in Q3 2021 was Avidity Partners Management, an estimated $61.7M sold.
Based on aggregated 13F filings for Q3 2021.